Impact of antithrombotic treatment on short-term outcomes after percutaneous coronary intervention for left main disease: a pooled analysis from REPLACE-2, ACUITY, and HORIZONS-AMI trials. [electronic resource]
Producer: 20150105Description: 97-104 p. digitalISSN:- 1969-6213
- Abciximab
- Aged
- Aged, 80 and over
- Antibodies, Monoclonal -- therapeutic use
- Anticoagulants -- therapeutic use
- Antithrombins -- therapeutic use
- Coronary Artery Disease -- therapy
- Eptifibatide
- Female
- Fibrinolytic Agents -- therapeutic use
- Hemorrhage -- prevention & control
- Heparin -- therapeutic use
- Hirudins
- Humans
- Immunoglobulin Fab Fragments -- therapeutic use
- Male
- Middle Aged
- Peptide Fragments -- therapeutic use
- Peptides -- therapeutic use
- Percutaneous Coronary Intervention -- methods
- Platelet Aggregation Inhibitors -- therapeutic use
- Platelet Glycoprotein GPIIb-IIIa Complex -- antagonists & inhibitors
- Randomized Controlled Trials as Topic
- Recombinant Proteins -- therapeutic use
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.